Severe aortic regurgitation and pulmonary hypertension in an 18‑year‑old patient after balloon aortic valvuloplasty (RCD code: IV‑5.A2)
Full Text:
Abstract
Keywords
References
Baumgartner H, Bonhoeffer, De Groot NMS, et al. Guidelines for the management of grown-up congenital heart disease. Eur Heart J 2010; 31: 2915–2957.
Hryniewiecki T, Gąsior Z, Rużyłło W. Wady serca. Medical Tribune Poland, Warszawa 2013; Vol 1: 223–226.
Olasińska-Wiśniewska A, Grygier M, Lesiak M, et al. Balloon aortic valvuloplasty – ups and downs – do we face the procedure comeback? Kardiol Pol. 2015; doi: 10.5603/KP.a2015.0158. [Epub ahead of print]
Vahanian A, Alfieri O, Andreotti F, et al. ESC Clinical Practice Guidelines: Management of Valvular Heart Disease. Eur Heart J 2012; 33: 2451–2496.
Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2016; 37: 67–119.
Tampakakis E, Leary PJ, Selby VN, et al. The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease. JACC Heart Fail 2015; 3:9–16.
Nowacka M, Kopeć G, Podolec P. Therapy with sildenafil in a patient with pulmonary hypertension associated with end-stage left ventricular failure. JRCD 2014; 1 (8): 32–37.
Jaquiss RDB. Bioprosthetic Aortic Valve Replacement in the Young: A Cautionary Tale. Circulation 2014; 130: 7–9.
Saleeb SF, Newburger JW, Geva T, et al. Accelerated Degeneration of a Bovine Pericardial Bioprosthetic Aortic Valve in Children and Young Adults. Circulation 2014; 130: 51–60.
McClure RS, Narayanasamy N, Wiegerinck E, et al. Late Outcomes for Aortic Valve Replacement with the Carpentier-Edwards Pericardial Bioprosthesis: Up to 17-Year Follow-Up in 1,000 Patients. Ann Thorac Surg 2010; 89:1410–1416.
DOI: http://dx.doi.org/10.20418%2Fjrcd.vol2no6.212
Refbacks
- There are currently no refbacks.